生命科学资讯

Organon pays $27.5M upfront to license Sebela's hormone-free copper IUD

Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking

Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months

Innovating Texture and Culture in Plant-Based Foods - News-Medical

Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market

Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance Singapore

Single Cell Multiomics Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

Thermo Fisher Scientific (TMO) Valuation Check As Datavant Data Partnership Draws Fresh Investor Interest - Yahoo! Finance Canada

Api Contract Manufacturing Market Is Going to Boom |• Lonza • Catalent - openPR.com

Thermo Fisher-Clario deal open for views in EU - MLex

Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push

Is It Time To Reassess Agilent Technologies (A) After Recent Share Price Weakness - Yahoo Finance

Is It Time To Revisit Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance UK

Hims reports 2025 earnings, shares details on GLP-1 pill decisions

What To Expect From Agilent's (A) Q4 Earnings - Finviz

The Bull Case For Illumina (ILMN) Could Change Following Buybacks And NovaSeq X Roadmap Reveal – Learn Why - simplywall.st

‘The perfect partner’: Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific

Size tuning of neural response variability in laminar circuits of macaque primary visual cortex

Waters Corporation to Present at the TD Cowen Health Care Conference - lelezard.com

FDA fleshes out new roadmap for testing personalized therapies